Uterine fibroids (also known as leiomyomas or myomas) are the most common benign uterine tumors. Aim of the study: We aimed to evaluate the role and potential of Magnetic resonance imaging (MRI) to add information to the ultrasound report by comparing the total number, size, and location of fibroids present. This is a comparative cross-sectional study including 50 patients, aged from 20 to 50 years; they were diagnosed as uterine fibroids patients by ultrasound. The data were obtained from the Picture Archiving and Communication system (PACs) from October 2021 to June 2022 G. The examination was performed on a GE, Philips, Mindray, and Hitashi ultrasound scanner and an MRI machine from Siemens 1.5T and 3T. The examination is done in the lower abdomen. The technique protocol meets the standard of the American Institute of Ultrasound in Medicine (AIUM). There are differences between Magnetic resonance imaging and ultrasound in the purpose of diagnosing uterine fibroids, in which a higher percentage is (100%) referred to diagnosing uterine fibroids by Magnetic resonance imaging. The analysis shows that 92% of the uterine fibroids were diagnosed by ultrasound and that 8% of the uterine fibroids were not diagnosed. In addition to ultrasound, we concluded that MRI could be preferentially utilized for and add some information for assessing Uterine fibroids especially small fibroids with a diameter of 1 cm or less.
IJPRAS
